Literature DB >> 15883165

Sphingosine activates protein kinase A type II by a novel cAMP-independent mechanism.

Yuefang Ma1, Stuart Pitson, Timothy Hercus, Jane Murphy, Angel Lopez, Joanna Woodcock.   

Abstract

Protein kinase A (PKA) has long been recognized as playing a major role in many regulatory processes in cells through its activation by the ubiquitous second messenger cAMP. We show here a novel mode of activation of PKA type II that is independent of cAMP and is, instead, dependent on sphingosine. PKA type II is specifically activated by sphingosine and its analog, dimethylsphingosine, but not by sphingosine-1-phosphate or other lipids. Like cAMP, sphingosine activates PKA holoenzyme but not the catalytic subunit alone, suggesting that the activation is mediated by the regulatory subunits. However, sphingosine-activated PKA, but not cAMP-activated PKA, is inhibited by phosphatidylserine, suggesting a distinct mechanism of activation. Furthermore, unlike cAMP, sphingosine does not induce the dissociation of PKA holoenzyme into catalytic and regulatory subunits. Modulation of sphingosine levels in vivo results in alteration in basal membrane-associated PKA activity consistent with a direct effect of membrane sphingosine on PKA type II. Importantly, sphingosine-dependent but not cAMP-dependent activation of PKA specifically phosphorylates Ser58 of the multifunctional adapter protein 14-3-3zeta, promoting the conversion of dimeric 14-3-3 to a monomeric state, thus potentially modulating several biological functions. These results define a new mode of PKA activation that is sphingosine-dependent and mechanistically different from the classical cAMP-dependent activation of PKA. Furthermore, they suggest that stimuli that induce sphingosine accumulation and modulate phospholipid content at the cell membrane have the potential to activate PKA, thereby inducing the phosphorylation of distinct substrates and biological activities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883165     DOI: 10.1074/jbc.M409081200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria.

Authors:  Christopher K Means; Birgitte Lygren; Lorene K Langeberg; Ankur Jain; Rose E Dixon; Amanda L Vega; Matthew G Gold; Susanna Petrosyan; Susan S Taylor; Anne N Murphy; Taekjip Ha; Luis F Santana; Kjetil Tasken; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.

Authors:  Fang Liu; Jing Huang; J Evan Sadler
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

3.  14-3-3-regulated Ca(2+)-dependent protein kinase CPK3 is required for sphingolipid-induced cell death in Arabidopsis.

Authors:  C Lachaud; E Prigent; P Thuleau; S Grat; D Da Silva; C Brière; C Mazars; V Cotelle
Journal:  Cell Death Differ       Date:  2012-08-31       Impact factor: 15.828

4.  Oral glucosylceramide reduces 2,4-dinitrofluorobenzene induced inflammatory response in mice by reducing TNF-alpha levels and leukocyte infiltration.

Authors:  Jingjing Duan; Tatsuya Sugawara; Shota Sakai; Kazuhiko Aida; Takashi Hirata
Journal:  Lipids       Date:  2011-01-11       Impact factor: 1.880

5.  Mys protein regulates protein kinase A activity by interacting with regulatory type Ialpha subunit during vertebrate development.

Authors:  Tomoya Kotani; Shun-ichiro Iemura; Tohru Natsume; Koichi Kawakami; Masakane Yamashita
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

6.  Vascular endothelial growth factor (VEGF) receptor-2 tyrosine 1175 signaling controls VEGF-induced von Willebrand factor release from endothelial cells via phospholipase C-gamma 1- and protein kinase A-dependent pathways.

Authors:  Yan Xiong; Yingqing Huo; Chao Chen; Huiyan Zeng; Xiaofan Lu; Chaoliang Wei; Changgeng Ruan; Xiaoyu Zhang; Zhenqian Hu; Masabumi Shibuya; Jincai Luo
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

7.  Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity.

Authors:  Michelle J Farquhar; Helen J Harris; Mandy Diskar; Sarah Jones; Christopher J Mee; Søren U Nielsen; Claire L Brimacombe; Sonia Molina; Geoffrey L Toms; Patrick Maurel; John Howl; Friedrich W Herberg; Sven C D van Ijzendoorn; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

8.  pH dependence of sphingosine aggregation.

Authors:  Hirotaka Sasaki; Hiromi Arai; Melanie J Cocco; Stephen H White
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

9.  Sphingolipids function as downstream effectors of a fungal PAQR.

Authors:  Nancy Y Villa; Brian R Kupchak; Ibon Garitaonandia; Jessica L Smith; Emilio Alonso; Charlene Alford; L Ashley Cowart; Yusuf A Hannun; Thomas J Lyons
Journal:  Mol Pharmacol       Date:  2008-12-09       Impact factor: 4.436

10.  Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity.

Authors:  Tamara M Leclercq; Paul A B Moretti; Mathew A Vadas; Stuart M Pitson
Journal:  J Biol Chem       Date:  2008-02-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.